The table below shows Bristol-Myers Squibb Company's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$11.49B
$12.22B
$12.27B
$11.20B
$11.89B
$12.20B
Cost of revenue
$3.42B
$3.44B
$3.37B
$3.03B
$2.96B
$3.27B
Gross profit
-
-
-
-
-
-
R&D
$2.65B
$2.53B
$2.58B
$2.26B
$2.37B
$2.90B
BMY annual revenue (10-K history)
Bristol-Myers Squibb Company reported annual revenue of $48.19B for fiscal year 2025. That is down 0.2% from $48.30B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $19.43B (FY 2016) to $48.19B. Figures come from the company's audited annual reports as filed with the SEC.
